We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Accelerated Approval of Oncology Drugs: Can We Do Better?
- Authors
Ellenberg, Susan S.
- Abstract
The author addresses the need for the accelerated approval of anti-cancer drugs. She explains the amendment of U.S. Food and Drug Administration (FDA) investigational new drug policies for accelerated drug approval. She introduces an article about the FDA experience with accelerated approval of oncological drugs and biologics. She considers the arguments involving the impact of accelerated approval on the availability of new oncology drugs.
- Subjects
UNITED States; DRUG approval; ANTINEOPLASTIC agents; UNITED States. Food &; Drug Administration; ONCOLOGY
- Publication
JNCI: Journal of the National Cancer Institute, 2011, Vol 103, Issue 8, p616
- ISSN
0027-8874
- Publication type
Editorial
- DOI
10.1093/jnci/djr104